Biotechnology Stocks I Performance Guide: BridgeBio Pharma, Inc. (BBIO)
BBIO has no dividends
Table and Chart of BBIO Performance
See what a $1,000 investment in BBIO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BBIO Returns | |
|---|---|
| Start Date | Jul-31-2019 |
| Start Price | $29.35 |
| End Date | Dec-01-2023 |
| End Price | $30.94 |
| # Prices | 54 |
| Min Date | May-31-2022 |
| Min Price | $6.83 |
| Max Date | Dec-31-2020 |
| Max Price | $71.11 |
| Total Return | 5.42% |
| Annualized Return | 1.18% |
| Current Value of $1,000 Purchase | $1,054 |
| Number Returns | 1,431 |
| Average Return | 1.16% |
| Number Profitable Returns | 575 |
| Percent Profitable Returns | 40.18% |
| Number Unprofitable Returns | 856 |
| Percent Unprofitable Returns | 59.82% |
| Profitable to Unprofitable Returns Ratio | 0.67 |
| BBIO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $5,382,539,000 | Price to Sales | 570.91 |
| Earnings per Share | $-3.9100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 123.68 |
| PRICE DATA | |
| 52 Week High | $36.36 |
| 52 Week Low | $6.64 |
| Analyst Target Price | $46.18 |
| 50-Day Moving Average | $26.98 |
| 200-Day Moving Average | $21.7 |
| FINANCIAL DATA | |
| Revenue per Share | $0.06 |
| Revenue | $9,428,000 |
| Profit Margin | 0% |
| Return on Equity | -17.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BBIO Compare Returns with S&P 500
BBIO Trendline Chart